https://www.marketscreener.com/quote/stock/ENLIVEX-THERAPEUTICS-LTD-56422776/news/Enlivex-Announces-Topline-Results-of-Its-Phase-II-Trial-Evaluating-Allocetra-in-Patients-with-Sepsi-46415507/?utm_source=telegram&utm_medium=social&utm_campaign=share